OUP user menu

Cardio NewsWire

Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days.

Free ESC Webinar series

Valve Atlas for iPad

NEW: EHJ Podcast

Dual antiplatelet treatment no benefit after 1 year from stenting

BCS 'A Year in Cardiology – 2014'

 

Free ESC Webinars for 2014

Check out the latest webinar recordings for free
ACCA Webinar on Prehospital management of cardiac Arrhythmia.

 

 

Clinical Atlas of Transcatheter Aortic Valve Therapies launched by PCR

The PCR Valve Atlas on aortic valve replacement has been launched as an iPad app. It contains 9 chapters primarily aimed at junior and intermediate practitioners, with a section on complications that will interest experienced interventionists.

Chapter one is focused on the anatomy of the aortic valve apparatus and shows Professor Robert Anderson (UK) describing human aortas on video.
Chapter two covers relevant imaging modalities with all variations of echocardiography, multi slice computed tomography (MSCT) and angiogram imagery.
The third chapter is a parade of all known valve devices that have a CE mark or are in the development pipeline.

Chapter four is dedicated to procedural concepts using moving images of implantations augmented with a 3D phantom model clearly illustrating the various mannerisms of implantations. This is one of the major novelties of the atlas.

The following chapter, five, is entitled complications and bailout procedures and covers the most common complications (cerebrovascular, MI, vascular, device related, etc), presented at the various PCR meetings across the globe. Each case is richly described and illustrated.

With the increased uptake of TAVI comes a need to interpret and treat failing valves with a
valve-in-valve procedure, and this can be found in chapter six. The last three chapters cover items of interest for parties who wish to start up their own TAVI programmes, including accessory equipment , the functioning of the heart valve team, and material set up lists for the TAVI operating table.

The atlas can be downloaded from the iTunes App Store

 

The new European Heart Journal Podcast series is launched

The EHJ with Oxford University Press are delighted to announce that Monday 17th November sees the launch of the first episode in the new, free, European Heart Journal podcast series.  The flagship podcast has been published alongside Dr Felix Mahfoud, and Professor Thomas Lüscher’s editorial "Renal denervation: Symply trapped by complexity?", which accompanies the Fast Track article "Predictors of blood pressure response in the SYMPLICITY HTN-3 trial" from David E. Kandzari et al.

The EHJ Podcast series joins the established suite of digital offerings from the EHJ, building pathways for cardiologists to discover and access the high-quality articles published in the Journal. Each podcast will publish in conjunction with a key Hotline Paper providing an audio summary of the article which can be downloaded and listened to for free.

Not only will cardiologists be able to access the EHJ Podcast series via links from the online table of contents and the Hotline Papers themselves, but individual episodes can be downloaded and listened to via podcast managers such as iTunes. You can also subscribe to the series and receive the latest episodes straight to your device.

With the addition of the EHJ Podcast series you can now listen, watch, and read cutting edge research from the EHJ anytime, anywhere.

The podcasts are available at: eurheartj.oxfordjournals.org/podcast

 

ARCTIC-Interruption trial finds no benefit of DAPT beyond 1 year after stenting

Dual antiplatelet treatment (DAPT) beyond 1 year after drug-eluting stent (DES) implantation provides no benefit and may be harmful in patients with no events in the first year, according to the results of the ARCTIC-Interruption trial.

The trial was a planned extension of the ARCTIC-Monitoring trial, which randomised 2440 patients to a strategy of platelet function testing with antiplatelet treatment adjustment or a conventional strategy after DES implantation. After 1 year, patients with no contraindication to interruption of DAPT were re-randomised to either interruption (624 patients) or continuation (635 patients) of DAPT for a further 6-18 months (ARCTIC-Interruption trial). The primary endpoint was a composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularisation, analysed by intention to treat.

After 17 months, there were no differences between the two groups in the primary endpoint, which occurred in 4% of patients in both groups. STEEPLE major bleeding events were more frequent in the continuation (1%) compared to the interruption group (<0.5%) but the difference was not significant. There were significantly more major or minor bleedings in the continuation (2%) versus the interruption group (1%) (p=0.04).

The trial demonstrates that 1 year after stenting just half of the patients could be randomised leading to selection of a low risk population. No conclusions can be made for high-risk patients as they were not randomised.

The authors recommend that guidelines be revisited in favour of shorter duration of DAPT after stenting.

The article can be found here.

 

British Cardiovascular Society ‘A Year in Cardiology – 2014’

‘A Year in Cardiology’ is a very popular one-day symposium, which returns to the Royal College of Physicians in London for its fourth year. Held annually at the end of the international conference calendar by the British Cardiovascular Society, it has rapidly become an essential opportunity for cardiologists to update themselves with the year’s most important developments in Cardiology.

The internationally renowned expert faculty will present a comprehensive review of the headline news for the year. The much anticipated keynote lecture this year will be given by Professor Philippe Gabriel Steg, Professor of Cardiology at the Université Paris and Imperial College London, a leading figure in coronary artery disease.

The morning session provides a succinct update on the important ESC and NICE Guideline updates, whilst the afternoon session reviewing key developments in all major cardiology subspecialties. At the end of each session delegates have the opportunity to pose questions to the speakers in the ‘Ask the Expert’ debate.

This year’s conference will be held on Friday 12 December 2014. The symposium is accredited by EBAC with delegates earning 6 CME or CPD for attendance.

For details on ‘A Year in Cardiology - 2014’ and other symposia run by the British Cardiovascular Society please see www.bcs.com/education/.

 

Back to top